NEW YORK STOCK EXCHANGE, INC. · MANE
-0.13% · -$0.1400 · Vol Not reported
Pre-market · updated 04:28:14 ET
Veradermics Inc

Veradermics Inc

Pharmaceuticals
$110.81
Card
Relationship Map

Follow $MANE

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MANE by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
MANE
Veradermics Inc
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

39/ 100
Veridion Score
Lower range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MANE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MANE catalysts
About Veradermics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2026
Employees
21
Country
US

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$110.95
Last session
Day high
$110.95
Last session
Day low
$110.95
Last session
Previous close
$110.95
52W high
$129.74
-14.59% from high
52W low
$37.03
80% of range
Market cap
$4.6B
EPS
$-3.7760
Beta
1.09
Shares out
41.8M
Avg volume
696.3K
VWAP
$110.95
Last session
Price history computed in-house
1W
-5.47%
1M
+6.72%
3M
-7.35%
SMA 50 $107.52 · above
SMA 200 Not reported · Not reported
52W position 80%

MANE overview

Veridion Score
39
Registered · 2026-10-07
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MANE.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MANE Form 4 filings
Public disclosures

Congress activity in MANE

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

MANE contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MANE in this window.
Lobbying spend

MANE lobbying filings, year to date.

Registered lobbying filings matched to Veradermics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MANE in this window.
Loading news for MANE
Analyst ratings
Sovereign unlock shows live analyst consensus for MANE.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.